Lior Teitelbaum
Directeur/Membre du Conseil chez Protekt Therapeutics Ltd.
Profil
Lior Teitelbaum was the founder of MindUP Ltd.
(founded in 2016) and held the title of Vice President-Business Development from 2016 to 2018.
Currently, Mr. Teitelbaum is a Senior Director at Johnson & Johnson Innovation - JJDC, Inc. since 2022.
Mr. Teitelbaum is also a Board of Director at FutuRx Ltd.
since 2019, a Director at ProteKt Therapeutics Ltd.
since 2019, and a Board member at A2i Therapeutics Ltd.
since 2021.
Previously, Mr. Teitelbaum worked as a Senior Director-Business Development at BioLineRx Ltd.
from 2012 to 2016, as a Director-Business Development & Marketing at Metacure Israel Ltd.
from 2010 to 2012, and as a Board Member at Pg Medical Systems Ltd.
from 2018 to 2019.
Mr. Teitelbaum holds an MBA from Tel-Aviv University, an undergraduate degree from The Hebrew University of Jerusalem (conferred in 2001), and a graduate degree from the Weizmann Institute of Science (conferred in 2004).
Postes actifs de Lior Teitelbaum
| Sociétés | Poste | Début |
|---|---|---|
Johnson & Johnson Innovation - JJDC, Inc.
 Johnson & Johnson Innovation - JJDC, Inc. Investment ManagersFinance Johnson & Johnson Innovation JJDC Inc (Johnson & Johnson Innovation JJDC) is a venture capital subsidiary of Johnson & Johnson founded in 1973. The firm is headquartered in New Brunswick, New Jersey. | Private Equity Investor | 01/02/2022 |
A2i Therapeutics Ltd.
 A2i Therapeutics Ltd. Investment ManagersFinance A2i Therapeutics Ltd. is an Israeli AI-based drug-design company that aims to develop novel therapeutic modulators of the protein ADAR1, a key element of the innate immune system. The company is a joint venture of the FutuRx Incubator and Atomwise, utilizing the AtomNet® AI platform and FutuRx’s technology to translate extraordinary technologies to life-changing therapies. | Directeur/Membre du Conseil | 01/01/2021 |
Protekt Therapeutics Ltd.
 Protekt Therapeutics Ltd. Pharmaceuticals: MajorHealth Technology Protekt Therapeutics Ltd. operates as a biopharmaceutical company. The firm develop a drug for enhancing the long-term memory of those suffering from mild cognitive impairment. The company is headquartered in Ness Ziona, Israel. | Directeur/Membre du Conseil | - |
FutuRx Ltd.
 FutuRx Ltd. Investment ManagersFinance FutuRx Ltd (FutuRx ) is a venture capital firm founded in 2014. The firm is headquartered in Ness Ziona. | Corporate Officer/Principal | 01/01/2019 |
Anciens postes connus de Lior Teitelbaum
| Sociétés | Poste | Fin |
|---|---|---|
| Pg Medical Systems Ltd. | Directeur/Membre du Conseil | 01/01/2019 |
| MindUP Ltd. | Fondateur | 01/12/2018 |
| BIOLINERX LTD. | Private Equity Investor | 01/05/2015 |
| Metacure Israel Ltd. | Sales & Marketing | 01/01/2012 |
Formation de Lior Teitelbaum
| Tel-Aviv University | Masters Business Admin |
| Weizmann Institute of Science | Graduate Degree |
| The Hebrew University of Jerusalem | Undergraduate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 1 |
|---|---|
| BIOLINERX LTD. | Health Technology |
| Entreprise privées | 7 |
|---|---|
Johnson & Johnson Innovation - JJDC, Inc.
Johnson & Johnson Innovation - JJDC, Inc. Investment ManagersFinance Johnson & Johnson Innovation JJDC Inc (Johnson & Johnson Innovation JJDC) is a venture capital subsidiary of Johnson & Johnson founded in 1973. The firm is headquartered in New Brunswick, New Jersey. | Finance |
A2i Therapeutics Ltd.
A2i Therapeutics Ltd. Investment ManagersFinance A2i Therapeutics Ltd. is an Israeli AI-based drug-design company that aims to develop novel therapeutic modulators of the protein ADAR1, a key element of the innate immune system. The company is a joint venture of the FutuRx Incubator and Atomwise, utilizing the AtomNet® AI platform and FutuRx’s technology to translate extraordinary technologies to life-changing therapies. | Finance |
Protekt Therapeutics Ltd.
Protekt Therapeutics Ltd. Pharmaceuticals: MajorHealth Technology Protekt Therapeutics Ltd. operates as a biopharmaceutical company. The firm develop a drug for enhancing the long-term memory of those suffering from mild cognitive impairment. The company is headquartered in Ness Ziona, Israel. | Health Technology |
FutuRx Ltd.
FutuRx Ltd. Investment ManagersFinance FutuRx Ltd (FutuRx ) is a venture capital firm founded in 2014. The firm is headquartered in Ness Ziona. | Finance |
| Metacure Israel Ltd. | |
| Pg Medical Systems Ltd. | |
| MindUP Ltd. |
